Prosalud Farma S.a. Pharmaceutical Import Profile — Paraguay (DGFT 2022–2026)

Name: Prosalud Farma S.a. Pharmaceutical Import Records from India — 2 Products, $324.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Prosalud Farma S.a. — Pharmaceutical Importer Profile (2026) | 2 Products, $324.1K Trade | TransData Nexus

Prosalud Farma S.a.

Pharmaceutical Importer · Paraguay · Analgesics & Antipyretics Focus · $324.1K Total Trade · DGFT Verified

Prosalud Farma S.a. is a pharmaceutical importer based in Paraguay with a total trade value of $324.1K across 2 products in 2 therapeutic categories. Based on 9 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Prosalud Farma S.a. sources from 6 verified Indian suppliers, with Rusan Pharma Limited accounting for 38.7% of imports.

Prosalud Farma S.a. — Import Portfolio & Supplier Network

Prosalud Farma S.a. import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Prosalud Farma S.a.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Rusan Pharma Limited	$212.2K	7	38.7%
United Biotech Private Limited	$192.0K	5	35.1%
Panacea Biotec Pharma Limited	$79.8K

What Formulations Does Prosalud Farma S.a. Import?

Formulation	Value	Ships
Fenstud 50 MCG/hr enpy fentanyl	$141.0K	4
Pharma product-amphotericin b	$100.0K	2
Pharma product:liposomal amphotericin	$50.0K	1
Panimun bioral 100 MG capsules (Each	$47.3K	1
Pharma produc-amphotericin b liposomal	$42.3K	1
Pharmaceutical medicinal products-ambilip (amphotericin b liposomal injection 50MG)bt.alli3a3,mfg dt-09/23	$42.3K	1
Fenstud patch 50mcg/hr p3(1x3)fentanilo(fenstud)50 MCG/hr, 6MG( 2000 x 3)bno:27502501 mfg:02/25 exp:01/28(6000 patches)	$38.1K	1
Panimun bioral 100 MG capsules (Each soft gelatin capsule contains cyclosporineusp 100 MG) b/n.306624002 m/d.11/2024	$32.5K	1
Fentanilo 0.05MG/ML ( 2ML ampoules) content : fentanyl 6 grmas bno: 23552401 mfg:12/2024 exp	$17.5K	1
Fentanilo 0.05MG/ML ( 2ML ampoules) basic drug/content : fentanyl 5.3 GM bno: 23552401 mfg:12.2024 exp : 11.2027	$15.6K	1
Oral rehydration salts BP 20.5GM BP	$7.6K	3
Pharma product-lyortam(ertapenem sodiumfor injection 1.0 g) batch no:eall3b17,mfg:12/2023	$7.5K	1
Oral rehydration salts 20.5 GM BP batchno. nv5017 mfg dt. 01/2025 exp dt. 12/2028 (9832 sachets)	$4.3K	1
Diagnostic kits iiai-200 kinetichrome anti-iia heparin/ enoxaparin test kit batch no.: r-082303 exp	$887	1
Xae-200 kinetichrome anti-xa heparin/enoxaparin test kit batch no.: r-072303 exp	$887	1

Prosalud Farma S.a. imports 15 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Fentanyl	Analgesics & Antipyretics	$174.1K	6	4.6%	3
2	Tiotropium	Respiratory	$150.0K	3	0.2%	9

Prosalud Farma S.a. imports 2 pharmaceutical products across 2 categories into Paraguay totaling $324.1K.

Prosalud Farma S.a. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Prosalud Farma S.A. is a leading pharmaceutical manufacturer based in Asunción, Paraguay. Established with a strong commitment to technological innovation and quality, the company has become a pioneer in the use of Blow-Fill-Seal (BFS) technology for the production of sterile injectables. This advanced manufacturing process ensures automated, secure, and human-free operations, enhancing product safety and efficacy. The company's industrial plant spans over 62,000 square meters, positioning Prosalud Farma S.A. as the Paraguayan laboratory with the largest infrastructure and technological development.

In addition to its manufacturing capabilities, Prosalud Farma S.A. serves as a significant importer of pharmaceutical products, particularly from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations valued at $324,000 USD across nine shipments. The primary products imported include Fentanyl and Tiotropium, which fall under the therapeutic categories of Analgesics & Antipyretics and Respiratory, respectively. This strategic sourcing complements their manufacturing operations, enabling Prosalud Farma S.A. to offer a comprehensive range of pharmaceutical products to the Paraguayan market.

2Distribution Network

Prosalud Farma S.A. operates a centralized distribution network from its headquarters in Asunción, Paraguay. The company's industrial plant, located at Capitán José Domingo Lombardo 2051, serves as the main hub for both manufacturing and distribution activities. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's substantial infrastructure suggests a robust capacity to manage and distribute pharmaceutical products efficiently within Paraguay. The strategic location in Asunción facilitates access to key transportation routes, enabling effective distribution across the country.

3Industry Role

Prosalud Farma S.A. plays a dual role in Paraguay's pharmaceutical supply chain. As a manufacturer, it produces a range of pharmaceutical products, including sterile injectables, utilizing advanced technologies such as Blow-Fill-Seal (BFS). This manufacturing capability allows the company to supply the domestic market with locally produced medications. Simultaneously, Prosalud Farma S.A. functions as an importer, sourcing finished pharmaceutical formulations from international suppliers, notably from India. This import activity enables the company to diversify its product offerings and meet the varied therapeutic needs of the Paraguayan population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Prosalud Farma S.a.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Prosalud Farma S.A.'s sourcing strategy exhibits a high degree of concentration, with the top five imported products accounting for 100% of the company's pharmaceutical imports from India between 2022 and 2026. The primary products imported are Fentanyl and Tiotropium, which are critical in the therapeutic areas of Analgesics & Antipyretics and Respiratory treatments, respectively. This focused sourcing approach indicates a strategic decision to concentrate on high-demand, specialized products that align with the company's manufacturing capabilities and market needs.

The shipment data reveals a stable relationship with Indian suppliers, with multiple shipments over the years. For instance, RUSAN PHARMA LIMITED and UNITED BIOTECH PRIVATE LIMITED have been consistent suppliers, indicating a reliable supply chain. However, the lack of diversification in sourcing could pose risks related to supply chain disruptions or changes in supplier dynamics. To mitigate potential risks, Prosalud Farma S.A. may consider exploring additional suppliers or diversifying its product portfolio to enhance supply chain resilience.

2Supply Chain Resilience

Prosalud Farma S.A.'s supply chain resilience is closely tied to its sourcing strategy from India. The company's reliance on a limited number of suppliers for its top imported products suggests a concentrated supply chain. While this concentration can lead to strong supplier relationships and streamlined operations, it also exposes the company to potential risks such as supply disruptions, geopolitical issues, or changes in supplier policies.

Importing Pharmaceuticals into Paraguay — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Paraguay

1Regulatory Authority & Framework

In Paraguay, the Dirección Nacional de Vigilancia Sanitaria (DINAVISA) is the primary regulatory authority overseeing the pharmaceutical sector. DINAVISA is responsible for the registration, authorization, and monitoring of pharmaceutical products, ensuring they meet the required safety, efficacy, and quality standards. The regulatory framework governing pharmaceutical imports is outlined in Decree No. 8342/95, which establishes regulations for pharmaceutical establishments and related entities. This decree partially amends provisions of Decree No. 187/50 and repeals Decree 1730/68, providing a comprehensive legal basis for the importation and distribution of pharmaceutical products in Paraguay.

The marketing authorization pathway for Indian generics involves several key steps. Initially, the product must be registered with DINAVISA, which includes submitting a detailed dossier containing information on the product's composition, manufacturing process, and clinical data. The registration process also requires compliance with Good Manufacturing Practice (GMP) standards, with DINAVISA recognizing certifications from reputable bodies such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, labeling requirements mandate that all information be provided in Spanish, ensuring clear communication with healthcare professionals and patients.

2Import Licensing & GMP

Prosalud Farma S.a. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Prosalud Farma S.A.'s focus on importing Fentanyl and Tiotropium aligns with the company's strategic emphasis on critical therapeutic areas. Fentanyl, a potent analgesic, addresses the significant demand for effective pain management solutions, particularly in surgical and oncology settings. Tiotropium, a bronchodilator, caters to the needs of patients with chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD). The decision to import these specific products is driven by the high prevalence of pain and respiratory disorders in Paraguay, necessitating reliable access to specialized medications.

The market demand for these products is substantial, given the aging population and the increasing incidence of chronic diseases. By focusing on these therapeutic areas, Prosalud Farma S.A. positions itself as a key provider of essential medications, enhancing its reputation and market share in the Paraguayan pharmaceutical sector. This strategic product focus also complements the company's manufacturing capabilities, allowing for a cohesive approach to meeting the healthcare needs of the population.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Prosalud Farma S.a.

What products does Prosalud Farma S.a. import from India?

Prosalud Farma S.a. imports 2 pharmaceutical products across 2 categories. Top imports: Fentanyl ($174.1K), Tiotropium ($150.0K).

Who supplies pharmaceuticals to Prosalud Farma S.a. from India?

Prosalud Farma S.a. sources from 6 verified Indian suppliers. The primary supplier is Rusan Pharma Limited (38.7% of imports, $212.2K).

What is Prosalud Farma S.a.'s total pharmaceutical import value?

Prosalud Farma S.a.'s total pharmaceutical import value from India is $324.1K, based on 9 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Prosalud Farma S.a. focus on?

Prosalud Farma S.a. imports across 2 categories. The largest: Analgesics & Antipyretics (53.7%), Respiratory (46.3%).

Get Full Prosalud Farma S.a. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.